One of the only medical record reviews solely using real-world data from hospitalized COVID-19 patients.
This week's Fierce LifeSci is brought to you by TriNetX. Trouble viewing? Click here. |
Date: Thursday, November 12, 2020 Time: 2pm ET / 11am PT Duration: 1 Hour |
|
TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), is building a regulatory-grade, enriched COVID-19 dataset that will dramatically enhance research of the virus. You are invited to join a webinar that will explore the ways researchers can leverage this enriched dataset for important COVID-19 research.
During the session, you will learn how this enriched dataset can help you: Support regulatory initiatives Characterize and follow disease progression in hospitalized patients, Identify previously unknown risk factors for contracting the virus Evaluate the effectiveness of inpatient treatments used in real-world clinical practice Set criteria for COVID-19 clinical trials Track changes in the course of patient care since early 2020 |
|
|
You are currently subscribed as newsletter@newslettercollector.com If you no longer wish to receive promotions from Fierce LifeSciences, simply unsubscribe. Refer to our Privacy Policy. Fierce LifeSciences is a division of Questex LLC. 685 3rd Ave 21st Floor New York, NY 10017 © 2020 Questex LLC. All Rights Reserved. Reproduction in whole or in part is prohibited without written permission. |
|
|